Turn Biotechnologies, Inc.
Mountain View, US · Founded 2018 · Delaware corporation · 1 known investors
mRNA/LNP based in vivo cell rejuvenation
Founders & leadership
VS
Vittorio SebastianoDirector
MQ
Marco QuartaDirector
SA
Sergio Andres Ruiz-ChinchillaExecutive Officer
DG
David GobelDirector
AK
Anja KrammerExecutive Officer, Director
RP
Ric PetersonExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$29.1MraisedSep 2023 · 55 investors · OtherRule 506(b)
▶$29.1MraisedSep 2023 · 55 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Vittorio SebastianoDirector
- Marco QuartaDirector
- Sergio Andres Ruiz-ChinchillaExecutive Officer
- David GobelDirector
- Anja KrammerExecutive Officer, Director
- Ric PetersonExecutive Officer
- Offering amount
- $43.9M
- Amount sold
- $29.1M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.